These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 16421173

  • 21. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.
    Bruck H, Leineweber K, Temme T, Weber M, Heusch G, Philipp T, Brodde OE.
    J Am Coll Cardiol; 2005 Dec 06; 46(11):2111-5. PubMed ID: 16325050
    [Abstract] [Full Text] [Related]

  • 22. [Association of PAI-1 gene polymorphism with prognosis of coronary artery disease].
    Zhang AY, Ji XW, Guan LX.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr 06; 25(2):233-5. PubMed ID: 18393255
    [Abstract] [Full Text] [Related]

  • 23. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI, Dos Reis RP, Freitas AI, Sousa AC, Pereira A, Faria P, Gomes S, Silva B, Santos N, Serrão M, Ornelas I, Freitas S, Araújo JJ, Brehm A, Cardoso AA.
    Rev Port Cardiol; 2008 Dec 06; 27(12):1539-55. PubMed ID: 19280995
    [Abstract] [Full Text] [Related]

  • 24. The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease.
    Rhee EJ, Oh KW, Lee WY, Kim SY, Jung CH, Kim BJ, Sung KC, Kim BS, Kang JH, Lee MH, Kim SW, Park JR.
    Metabolism; 2006 Oct 06; 55(10):1344-51. PubMed ID: 16979405
    [Abstract] [Full Text] [Related]

  • 25. Effects of polymorphisms in beta1-adrenoceptor and alpha-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study.
    Nieminen T, Lehtimäki T, Laiho J, Rontu R, Niemelä K, Kööbi T, Lehtinen R, Viik J, Turjanmaa V, Kähönen M.
    J Appl Physiol (1985); 2006 Feb 06; 100(2):507-11. PubMed ID: 16210433
    [Abstract] [Full Text] [Related]

  • 26. Gene-gene interaction affects coronary artery disease risk.
    Mendonça MI, Dos Reis RP, Freitas AI, Sousa AC, Pereira A, Faria P, Gomes S, Silva B, Santos N, Serrao M, Ornelas I, Freitas S, Freitas C, Araújo JJ, Brehm A, Cardoso AA.
    Rev Port Cardiol; 2009 Apr 06; 28(4):397-415. PubMed ID: 19634497
    [Abstract] [Full Text] [Related]

  • 27. Adrenergic beta1 receptor polymorphism (Ser49Gly) is associated with obesity in type II diabetic patients.
    Nonen S, Yamamoto I, Liu J, Maeda M, Motomura T, Igarashi T, Fujio Y, Azuma J.
    Biol Pharm Bull; 2008 Feb 06; 31(2):295-8. PubMed ID: 18239290
    [Abstract] [Full Text] [Related]

  • 28. Polymorphism in the beta(1)-adrenergic receptor gene and hypertension.
    Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Råstam L, Groop L.
    Circulation; 2001 Jul 10; 104(2):187-90. PubMed ID: 11447084
    [Abstract] [Full Text] [Related]

  • 29. The Arg389Gly beta1-adrenergic receptor gene polymorphism and susceptibility to faint during head-up tilt test.
    Márquez MF, Hernández-Pacheco G, Hermosillo AG, Gómez JR, Cárdenas M, Vargas-Alarcón G.
    Europace; 2007 Aug 10; 9(8):585-8. PubMed ID: 17463065
    [Abstract] [Full Text] [Related]

  • 30. Polymorphic variants of beta1 adrenergic receptor gene (Ser49Gly & Arg389Gly) in healthy Tamilian volunteers.
    Ramu P, Mahesh Kumar KN, Shewade DG, Swaminathan RP, Dutta TK, Balachander J, Adithan C.
    Indian J Med Res; 2010 Jul 10; 132():62-6. PubMed ID: 20693591
    [Abstract] [Full Text] [Related]

  • 31. Influence of angiotensinogen and angiotensin-converting enzyme polymorphisms on cardiac hypertrophy and improvement on maximal aerobic capacity caused by exercise training.
    Alves GB, Oliveira EM, Alves CR, Rached HR, Mota GF, Pereira AC, Rondon MU, Hashimoto NY, Azevedo LF, Krieger JE, Negrão CE.
    Eur J Cardiovasc Prev Rehabil; 2009 Aug 10; 16(4):487-92. PubMed ID: 19404196
    [Abstract] [Full Text] [Related]

  • 32. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
    Terra SG, Hamilton KK, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS, Belgado BS, Hill JA, Aranda JM, Yarandi HN, Johnson JA.
    Pharmacogenet Genomics; 2005 Apr 10; 15(4):227-34. PubMed ID: 15864115
    [Abstract] [Full Text] [Related]

  • 33. Adrenergic Receptor Polymorphism and Maximal Exercise Capacity after Orthotopic Heart Transplantation.
    Métrich M, Mehmeti F, Feliciano H, Martin D, Regamey J, Tozzi P, Meyer P, Hullin R, Swiss Transplant Cohort Study.
    PLoS One; 2016 Apr 10; 11(9):e0163475. PubMed ID: 27669015
    [Abstract] [Full Text] [Related]

  • 34. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
    Ozkök E, Aydin M, Babalik E, Ozbek Z, Ince N, Kara I.
    Med Sci Monit; 2008 Oct 10; 14(10):CR536-42. PubMed ID: 18830194
    [Abstract] [Full Text] [Related]

  • 35. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.
    Vogiatzi K, Voudris V, Apostolakis S, Kochiadakis GE, Thomopoulou S, Zaravinos A, Spandidos DA.
    Thromb Res; 2009 May 10; 124(1):84-9. PubMed ID: 19201454
    [Abstract] [Full Text] [Related]

  • 36. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.
    Baessler A, Fischer M, Mayer B, Koehler M, Wiedmann S, Stark K, Doering A, Erdmann J, Riegger G, Schunkert H, Kwitek AE, Hengstenberg C.
    Hum Mol Genet; 2007 Apr 15; 16(8):887-99. PubMed ID: 17324965
    [Abstract] [Full Text] [Related]

  • 37. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
    Kaman D, Ilhan N, Metin K, Akbulut M, Ustündağ B.
    Cell Biochem Funct; 2009 Mar 15; 27(2):88-92. PubMed ID: 19226538
    [Abstract] [Full Text] [Related]

  • 38. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study.
    Manfredi S, Federici C, Picano E, Botto N, Rizza A, Andreassi MG.
    Mutat Res; 2007 Aug 01; 621(1-2):106-12. PubMed ID: 17408703
    [Abstract] [Full Text] [Related]

  • 39. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT, Gong Y, Terra SG, Beitelshees AL, Langaee TY, Pauly DF, Schofield RS, Hamilton KK, Herbert Patterson J, Adams KF, Hill JA, Aranda JM, Johnson JA.
    Pharmacogenet Genomics; 2007 Apr 01; 17(4):277-82. PubMed ID: 17496726
    [Abstract] [Full Text] [Related]

  • 40. Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses.
    Brodde OE.
    Pharmacol Ther; 2008 Jan 01; 117(1):1-29. PubMed ID: 17916379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.